Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 37.0 | 67 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 26.0 | 65 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 28.0 | 78 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 31.0 | 66 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 26.0 | 70 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 39.0 | 81 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 37.0 | 70 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 38.0 | 85 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 38.0 | 77 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 28.0 | 67 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | PDGF-BB | 33.0 | 68 | |
RA2159 | 3 | PDGF-BB | 24.0 | 73 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | PDGF-BB | 26.0 | 79 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | PDGF-BB | 25.0 | 81 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | PDGF-BB | 25.0 | 76 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | PDGF-BB | 25.0 | 77 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | PDGF-BB | 23.0 | 62 | ||||
RA2159 | 3 | PDGF-BB | 28.0 | 84 | |||||||
N2586 | 3 | PDGF-BB | 24.0 | 61 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | PDGF-BB | 28.0 | 84 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | PDGF-BB | 22.0 | 67 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | PDGF-BB | 24.0 | 72 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | PDGF-BB | 23.0 | 65 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | PDGF-BB | 22.0 | 81 | ||||
N2586 | 3 | PDGF-BB | 28.0 | 57 |